65 related articles for article (PubMed ID: 1135607)
21. Adverse effect of dopamine on portal venous pressure.
Kibbey W; Sirinek KR; Thomford NR; Pace WG
Rev Surg; 1977; 34(3):202-5. PubMed ID: 866979
[No Abstract] [Full Text] [Related]
22. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.
Escorsell A; Bordas JM; Castañeda B; Llach J; García-Pagán JC; Rodés J; Bosch J
Hepatology; 2000 May; 31(5):1061-7. PubMed ID: 10796880
[TBL] [Abstract][Full Text] [Related]
23. Losartan in preascitic cirrhosis.
Castaño G; Viudez P; Sookoian S
Am J Gastroenterol; 2004 Nov; 99(11):2282-3. PubMed ID: 15555016
[No Abstract] [Full Text] [Related]
24. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
25. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
Barr JW; Lakin RC; Rösch J
Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
[TBL] [Abstract][Full Text] [Related]
26. Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study.
McCormick PA; Biagini MR; Dick R; Greenslade L; Chin J; Cardin F; Wagstaff D; McIntyre N; Burroughs AK
Hepatology; 1992 Nov; 16(5):1180-6. PubMed ID: 1427656
[TBL] [Abstract][Full Text] [Related]
27. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
[TBL] [Abstract][Full Text] [Related]
28. Arterial vasopressin infusions: science or seance?
Nusbaum M; Conn HO
Gastroenterology; 1975 Jul; 69(1):263-7. PubMed ID: 1097293
[No Abstract] [Full Text] [Related]
29. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation.
Wagener G; Gubitosa G; Renz J; Kinkhabwala M; Brentjens T; Guarrera JV; Emond J; Lee HT; Landry D
Liver Transpl; 2008 Nov; 14(11):1664-70. PubMed ID: 18975276
[TBL] [Abstract][Full Text] [Related]
30. Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis.
López P; Otaso JC; Alvarez D; Rojter S; Podestá A; Albornoz L; Terg R; Romero G; Mastai R
Acta Gastroenterol Latinoam; 1997; 27(2):59-62. PubMed ID: 9339235
[TBL] [Abstract][Full Text] [Related]
31. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
[TBL] [Abstract][Full Text] [Related]
33. Effect of vasoactive drugs on hepatic haemodynamics in bilharzial liver cirrhosis.
Fayez MA; el-Saadani AM; el-Gengehy MT; Aziz S; Othman O; Habib EM
J Egypt Med Assoc; 1972; 55(8):567-76. PubMed ID: 4658036
[No Abstract] [Full Text] [Related]
34. [Dose-dependent acute effect and long-term modification by molsidomine of portal and cardiac hemodynamics in patients with liver cirrhosis].
Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
Med Klin (Munich); 1994 Jul; 89 Suppl 2():65-8, 76. PubMed ID: 7968910
[No Abstract] [Full Text] [Related]
35. Effects of vasopressin on left gastric venous flow in cirrhotic patients with esophageal varices.
Ohnishi K; Sato S
Am J Gastroenterol; 1990 Mar; 85(3):293-5. PubMed ID: 2178400
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic effects of superior mesenteric arterial and intravenous vasopressin infusions in patients with portal hypertension.
Kaufman SL; Maddrey WC; Harrington DP; White RI
Invest Radiol; 1977; 12(3):210-4. PubMed ID: 863624
[TBL] [Abstract][Full Text] [Related]
37. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis b-related cirrhosis.
Lee FY; Tsai YT; Lin HC; Lee SD; Hsia HC; Lin WJ; Wang SS; Lai KH; Lo KJ
J Hepatol; 1992 May; 15(1-2):54-8. PubMed ID: 1506656
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic and metabolic effects of vasopressin in acute hemorrhagic pancreatitis.
Pissiotis CA; Van Meter SW; Condon RE
Eur Surg Res; 1973; 5(1):64-72. PubMed ID: 4540023
[No Abstract] [Full Text] [Related]
40. Effect of cimetidine on portal pressure and systemic hemodynamics in patients with and without liver cirrhosis.
Nagasue N; Ogawa Y; Yukaya H; Okita M; Yamamoto M; Higashi T
Gastroenterol Jpn; 1985 Apr; 20(2):131-6. PubMed ID: 4029550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
